Peripheral cell wall lipids of Mycobacterium tuberculosis are inhibitory to surfactant function

Tuberculosis

Volumn 88, Issue 3, 2008, Pages 178-186

  Wang, Zhengdong ^a   Schwab, Ute ^b   Rhoades, Elizabeth ^b   Chess, Patricia R ^a   Russell, David G ^b   Notter, Robert H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

ALI ARDS; Lung surfactant; Mycobacterium tuberculosis; Surfactant dysfunction; Surfactant inhibition; Trehalose dimycolate

Indexed keywords

CORD FACTOR; LIPID; LUNG SURFACTANT; MANNOSIDE; PHOSPHATIDYLINOSITOL;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BREATHING PATTERN; CHROMATOGRAPHY; DISEASE EXACERBATION; LUNG ALVEOLUS SURFACE TENSION; LUNG INJURY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PURIFICATION; SURFACE PROPERTY;

ANIMALS; CATTLE; CELL WALL; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPIDS; MYCOBACTERIUM TUBERCULOSIS; PULMONARY SURFACTANTS; SURFACE TENSION;

EID: 43049103768     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.11.003     Document Type: Article

References (51)

1. Hopewell P.C., and Pai M. Tuberculosis, vulnerability, and access to quality care. JAMA 293 (2005) 2790-2793
2. Raviglione M.C., and Uplekar M. WHO's new stop TB strategy. Lancet 367 (2006) 952-955
3. World Health Organization (WHO). Global tuberculosis: control, surveillance, planning, financing. WHO report 2006 (Document WHO/HTM/TB/2006.362). Geneva, Switzerland; 2006. p. 1-242.
4. Mandell G.L., Bennett J.E., and Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases (2000), Churchill Livingstone, New York
5. World Health Organization (WHO). Tuberculosis infection control in an era of expanding HIV care and treatment. Addendum to WHO guidelines for the prevention of tuberculosis in health care facilites in resource-limited settings, 1999. Geneva, Switzerland; 2006. p. 1-23.
6. Corbett E.L., Watt C.J., Walker N., Maher D., Williams B.G., Raviglione M.C., et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Internal Med 163 (2003) 1009-1021
7. Russell D. Who puts the tubercle in tuberculosis?. Nat Rev Microbiol 5 (2007) 39-47
8. Davies J., Turner M., and Klein N. The role of the collectin system in pulmonary defense. Paediatr Respir Rev 2 (2001) 70-75
9. Floros J., Lin H.M., Garcia A., Salazar M.A., Guo X., DiAngelo S., et al. Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J Infect Dis 182 (2000) 1473-1478
10. Haataja R., and Hallman M. Surfactant proteins as genetic determinants of multifactorial pulmonary diseases. Ann Med 34 (2002) 324-333
11. Malik S., Greenwood C.M., Eguale T., Kifle A., Beyene J., Habte A., et al. Variants of the SFTPA1 and SFTPA2 genes and susceptibility to tuberculosis in Ethiopia. Hum Genet 118 (2006) 752-759
12. Beharka A.A., Gaynor C.D., Kang B.K., Voelker D.R., McCormack F.X., and Schlesinger L.S. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 169 (2002) 3565-3573
13. Ferguson J.S., Martin J.L., Azad A.K., McCarthy T.R., Kang P.B., Voelker D.R., et al. Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect Immun 74 (2006) 7005-7009
14. Ferguson J.S., Voelker D.R., McCormack F.X., and Schlesinger L.S. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 163 (1999) 312-321
15. Ferguson J.S., Voelker D.R., Ufnar J.A., Dawson A.J., and Schlesinger L.S. Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. J Immunol 168 (2002) 1309-1314
16. Chimote G., and Banerjee R. Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity. Colloids Surf B: Biointerfaces 45 (2005) 215-223
17. Notter R.H. Lung surfactants: basic science and clinical applications (2000), Marcel Dekker Inc., New York
18. Beatty W.L., Rhoades E.R., Ullrich H.J., Chatterjee D., Heuser J.E., and Russell D.G. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1 (2000) 235-247
19. Enhorning G. Pulsating bubble technique for evaluation of pulmonary surfactant. J Appl Physiol 43 (1977) 198-203
20. Hall S.B., Bermel M.S., Ko Y.T., Palmer H.J., Enhorning G.A., and Notter R.H. Approximations in the measurement of surface tension with the oscillating bubble surfactometer. J Appl Physiol 75 (1993) 468-477
21. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
22. Rhoades E., Hsu F.-F., Torrelles J.B., Turk J., Chatterjee D., and Russell D.G. Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol Microbiol 48 (2003) 875-888
23. Valway S.E., Sanchez M.P.C., Shinnick T.F., Orme I., Agerton T., Hoy D., et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 338 (1998) 633-639
24. Khoo K.H., Dell A., Morris H.R., Brennan P.J., and Chatterjee D. Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: definition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology 5 (1995) 117-127
25. Ames B.N. Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol 8 (1966) 115-118
26. Holm B.A., and Notter R.H. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 63 (1987) 1434-1442
27. Wang Z., Foye A., Chang Y., Chess P.R., Wright T.W., Bhagwat S., et al. Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro. Am J Physiol: Lung Cell Mol Physiol 288 (2005) L1124-L1131
28. Wang Z., and Notter R.H. Additivity of protein and non-protein inhibitors of lung surfactant activity. Am J Respir Crit Care Med 158 (1998) 28-35
29. Besra G., and Chatterjee D. Lipids and carbohydrates of mycobacterium tuberculosis. In: Bloom B. (Ed). Tuberculosis: pathogenesis, protection, and control (1994), American Society for Microbiology Press, Washington, DC 285-306
30. Anderson R. The chemistry of lipids of tubercle bacilli. Harvey Lect 35 (1940) 271-313
31. Geisel R.E., Sakamoto K., Russell D.G., and Rhoades E.R. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J Immunol 174 (2005) 5007-5015
32. Wang Z., Holm B.A., Matalon S., and Notter R.H. Surfactant activity and dysfunction in lung injury. In: Notter R.H., Finkelstein J.N., and Holm B.A. (Eds). Lung injury: mechanisms, pathophysiology, and therapy (2005), Taylor Francis Group Inc., Boca Raton 297-352
33. Seeger W., Günther A., Walmrath H.D., Grimminger F., and Lasch H.G. Alveolar surfactant and adult respiratory distress syndrome. Pathogenic role and therapeutic prospects. Clin Invest 71 (1993) 177-190
34. Holm B.A., Enhorning G., and Notter R.H. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 49 (1988) 49-55
35. Holm B.A., Notter R.H., and Finkelstein J.H. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 38 (1985) 287-298
36. Seeger W., Grube C., Günther A., and Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6 (1993) 971-977
37. Seeger W., Stohr G., Wolf H.R.D., and Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58 (1985) 326-338
38. Holm B.A., Wang Z., and Notter R.H. Multiple mechanisms of lung surfactant inhibition. Pediatr Res 46 (1999) 85-93
39. Hall S.B., Lu Z.R., Venkitaraman A.R., Hyde R.W., and Notter R.H. Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics. J Appl Physiol 72 (1992) 1708-1716
40. Seeger W., Lepper H., Hellmut R.D., and Neuhof H. Alteration of alveolar surfactant function after exposure to oxidant stress and to oxygenated and native arachadonic acid in vitro. Biochim Biophys Acta 835 (1985) 58-67
41. Wright T.W., Notter R.H., Wang Z., Harmsen A.G., and Gigliotti F. Pulmonary inflammation disrupts surfactant function during P. carinii pneumonia. Infect Immun 69 (2001) 758-764
42. Wright T.W., Pryhuber G., Chess P.R., Wang Z., Notter R.H., and Gigliotti F. TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis carinii pneumonia. J Immunol 172 (2004) 2511-2522
43. Russo T.A., Bartholomew L.A., Davidson B.A., Helinski J.D., Carlino U.B., Knight P.R., et al. Total extracellular surfactant is increased but abnormal in a rat model of Gram-negative bacterial pneumonitis. Am J Physiol 283 (2002) L655-L663
44. Russo T.A., Wang Z., Davidson B.A., Genagon S.A., Beanan J.M., Olsen R., et al. Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model. Am J Physiol 292 (2007) L632-L643
45. Notter R.H., Wang Z., Egan E.A., and Holm B.A. Component-specific surface and physiological activity in bovine-derived lung surfactants. Chem Phys Lipids 114 (2002) 21-34
46. Willson D.F., Bauman L.A., Zaritsky A., Dockery K., James R.L., Stat M., et al. Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care Med 27 (1999) 188-195
47. Willson D.F., Jiao J.H., Bauman L.A., Zaritsky A., Craft H., Dockery K., et al. Calf lung surfactant extract. Crit Care Med 24 (1996) 1316-1322
48. Auten R.L., Notter R.H., Kendig J.W., Davis J.M., and Shapiro D.L. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 87 (1991) 101-107
49. Willson D.F., Thomas N.J., Markovitz B.P., DiCarlo J.V., Pon S., Jacobs B.R., et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 293 (2005) 470-476
50. Beatty W.L., Ullrich H.J., and Russell D.G. Mycobacterial surface moieties are released from infected macrophages by a constitutive exocytic event. Eur J Cell Biol 80 (2001) 31-40
51. Hunter R.L., Olsen M., Jagannath C., and Actor J.K. Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci 36 (2006) 371-386